 |
 |
||||
 |
|||||
BOOKMARK THIS PAGE
About UsCompany ProfileAlfa Wassermann Separation Technologies (AWST) is a leader in ultracentrifugation solutions for process development and industrial scale manufacturing, exploiting around 40 years of industry-leading continuous flow ultracentrifugation experience of its parent, Alfa Wassermann, Inc. (AWI). The bioprocess industry has relied on Alfa Wassermann continuous flow ultracentrifuges to efficiently and reliably separate viruses in the development and manufacture of life-saving vaccines and other bioproducts. The AW Promatix 1000™ is designed to develop methodologies for the separation, fractionation and concentration of viral vectors, virus-like particles, viruses, viral and bacterial vaccines, macromolecules and cellular organelles. The strength of the system is its versatility; with full programmability for successful separation protocols, automated fraction collection system to facilitate analysis and linear scale-up to pilot scale and full production. The PKII Ultracentrifuge System is the ideal choice for process development and small scale production. It is designed to fit in the laboratory with low sample volume, revolutionizing your downstream process with linear scale-up. The KII model is built for industrial scale production – the ultracentrifuge for commercial vaccine manufacturing that is fully validated to meet cGMP. Increase final yield with the KII’s simplified purification process, which reduces typical multi-step processes and costly column matrices. Together with our wide range of rotors, these units permit protocols to be transferred directly from lab scale volumes of one liter through pilot plant level to two hundred liter process volumes without any modification of the protocol. This patented scale-up technology provides substantial time and cost savings to manufacturers.
|
|
|
© 2007 Alfa Wassermann Separation Technologies | All Rights Reserved. |
 |